Discover 332 paid clinical trials in New Mexico. Search by city or condition to find a research study near you that matches your needs across various therapeutic areas.
New Mexico provides a wide selection of paid research opportunities for both healthy volunteers and individuals with specific health conditions. Leading research sites in Albuquerque, Santa Fe, and Las Cruces are actively recruiting, offering early access to innovative treatments and exceptional healthcare.
Filter
1
Filter results
Results: 332
A Phase 2 Study and Open-Label Extension of NEU-411 in Companion Diagnostic-Positive Participants With Early Parkinson's Disease
Location: Boston MA, Manhasset NY, New York NY, Philadelphia PA,
Sponsor: Neuron23 Inc.
Sex: All
Age: 40 - 70+
Code: NCT06680830
Phase 2, Recruiting
Comparing Retreatment of 177Lu-DOTATATE PRRT Versus the Usual Treatment in Patients With Metastatic Unresectable Gastroenteropancreatic Neuroendocrine Tumors, NET RETREAT Trial
for
Metastatic Digestive System Neuroendocrine Tumor G1,
Location: St. John's, Quebec, Ottawa, Rochester NY,
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 18+
Code: NCT05773274
Phase 2, Recruiting
Suicide in Urban Natives: Detection and Networks to Combat Events
for
Suicide Prevention
Location: Albuquerque NM
Sponsor: University of Colorado, Denver
Sex: All
Age: 18 - 34
Code: NCT03136094
Recruiting
CSP #2026 - Beta Blocker Dialyzability on Cardiovascular Outcomes
for
End-Stage Kidney Disease, End-Stage Renal Disease
Location: Philadelphia PA, Durham NC, Pittsburgh PA,
Sponsor: VA Office of Research and Development
Sex: All
Age: 18+
Code: NCT05931276
Phase 3, Recruiting
A Phase I/IIa Study of AZD8205 Given Alone or Combined, in Participants With Advanced/Metastatic Solid Malignancies
for
Breast Cancer, Biliary Tract Carcinoma, Ovarian Cancer,
Location: Boston MA, Commack NY, Baltimore MD, Ottawa, Toronto,
Sponsor: AstraZeneca
Sex: All
Age: 18+
Code: NCT05123482
Phase 1, Phase 2, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Uterine Preservation Via Lifestyle Transformation
for
Endometrial Hyperplasia, Grade 1 Endometrial Cancer
Location: St Louis MO, Oklahoma City OK, Albuquerque NM
Sponsor: Washington University School of Medicine
Sex: Female
Age: 18+
Code: NCT05903131
Phase 2, Recruiting
A Study of Amivantamab in Combination With Lazertinib, or Amivantamab in Combination With Platinum-Based Chemotherapy, for Common Epidermal Growth Factor Receptor (EGFR)-Mutated Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC)
for
Carcinoma, Non-Small-Cell Lung
Location: Boston MA, Shirley NY, New Haven CT, Lebanon NH,
Sponsor: Janssen Research & Development, LLC
Sex: All
Age: 18+
Code: NCT06667076
Phase 2, Recruiting
Ordastobart (INBRX-106) Add-on to Pembrolizumab in 1L HPV+ PD-L1+ R/M OPSCC (HexAgon-HN)
for
Head and Neck Squamous Cell Carcinoma (HNSCC),
Location: Richmond VA, Chapel Hill NC, Miami FL, Pittsburgh PA,
Sponsor: Inhibrx Biosciences, Inc
Sex: All
Age: 18+
Code: NCT06295731
Phase 2, Phase 3, Recruiting
Inflammation and Medical Provider Attitudes, Cognition, and Treatment Decisions Study
for
Decision-Making, Patient Care, Treatment Decisions
Location: Roanoke VA, Fayetteville AR, Albuquerque NM
Sponsor: University of Arkansas, Fayetteville
Sex: All
Age: 18+
Code: NCT07842367
Phase 2, Recruiting
This Study is a Non-interventional Disease Registry of Adolescent and Adult Patients With Atopic Dermatitis Who Initiate or Switch Any Systemic Treatment
for
Atopic Dermatitis
Location: Portsmouth NH, Warwick RI, Falls Church VA,
Sponsor: Sanofi
Sex: All
Age: 12+
Code: NCT07290803
Recruiting
Psilocybin for Opioid Use Disorder (OUD)
for
Opioid Use Disorder
Location: The Bronx NY, Brooklyn NY, New York NY, Albuquerque NM
Sponsor: NYU Langone Health
Sex: All
Age: 18 - 65
Code: NCT06796062
Phase 2, Recruiting
Surgical Thromboprophylaxis Practices in Oncology Patients Within the NCORP Network, STOP-VTE Study
for
Malignant Digestive System Neoplasm,
Location: Portland ME, Scarborough ME, The Bronx NY, Newark DE,
Sponsor: Wake Forest University Health Sciences
Sex: All
Age: 18+
Code: NCT07215624
Recruiting
A Study to Evaluate the Efficacy and Safety of Divarasib Compared With Investigator's Choice of Immunotherapy or Observation in Participants With Resected Stage II-III KRAS G12C-Positive Non-Small Cell Lung Cancer (NSCLC)
for
Non-small Cell Lung Cancer
Location: Montreal, Farmington Hills MI, Atlanta GA,
Sponsor: Hoffmann-La Roche
Sex: All
Age: 18+
Code: NCT07541170
Phase 3, Recruiting
A Master Protocol to Investigate Efficacy and Safety of Elecoglipron in Participants With Obesity or Overweight With or Without T2DM
for
Weight Management
Location: Truro, Moncton, Long Island City NY, Laurelton NY,
Sponsor: AstraZeneca
Sex: All
Age: 18+
Code: NCT07667803
Phase 3, Recruiting
A Clinical Trial of MK-7262 and Enlicitide in Participants With High Lipoprotein(a) (MK-7262-004)
A Study to Evaluate the Efficacy and Safety of Elismetrep (K-304) in the Acute Treatment of Migraine
for
Migraine
Location: Boston MA, Waltham MA, Waterbury CT, Commack NY,
Sponsor: Kallyope Inc.
Sex: All
Age: 18 - 70+
Code: NCT07645924
Phase 3, Recruiting
A Study to Evaluate Efficacy, Safety, and Immunogenicity With ABP 938 8 mg Versus EYLEA® HD (Aflibercept) in Participants With Neovascular Age-related Macular Degeneration